|
|
|
SENSEX
|
|
-609.28
|
-0.82%
|
73730.16
|
|
|
NIFTY
|
|
-150.40
|
-0.67%
|
22419.95
|
|
|
Nasdaq
|
|
-100.99
|
-0.64%
|
15611.76
|
|
|
Nikkei 225
|
|
-831.60
|
-2.16%
|
37628.48
|
|
|
FTSE 100
|
|
38.48
|
0.48%
|
8078.86
|
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
24-04-2024
|
|
|
Jubilant Pharmova Limited has informed the Exchange regarding 'Jubilant Pharmova announces completion of USFDA audit of Radiopharmaceuticals manufacturing facility at Montreal, Canada'. |
|
|
|
18-04-2024
|
|
|
Jubilant Pharmova Limited has informed the Exchange regarding 'Closure of manufacturing operations of Solid dosage formulation facility of Jubilant Cadista Pharmaceuticals Inc., USA ( Jubilant Cadista ), a subsidiary, located at Salisbury, Maryland, USA. |
|
|
|
17-04-2024
|
|
|
Jubilant Pharmova Limited has informed the Exchange regarding 'USFDA Communication - Roorkee Facility'. |
|
|
|
12-04-2024
|
|
|
ï¿‚ï¾ HSB Trustee Company Private Limited,HS Trustee Company Private Limitedï¿‚ï¾ has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaï¿‚ï¾ (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
|
|
10-04-2024
|
|
|
Jubilant Pharmova Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
|
|
05-04-2024
|
|
|
Significant increase in volume has been observed in Jubilant Pharmova Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Jubilant Pharmova Limited has submitted their response. |
|
|
|
04-04-2024
|
|
|
Jubilant Pharmova Limited has informed the Exchange about Loss of Share Certificates |
|
|
|
04-04-2024
|
|
|
Jubilant Pharmova Limited has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation |
|
|
|
04-04-2024
|
|
|
Significant increase in volume has been observed in Jubilant Pharmova Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
|
|
|
02-04-2024
|
|
|
Jubilant Pharmova Limited has informed the Exchange about Loss of Share Certificates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|